Magellan Biosciences, Inc.

Magellan Biosciences, Inc., through its subsidiaries, manufactures and markets point-of-care analyzers and automated systems for hospital-based labs and near-patient testing in the United States and internationally. It offers automated workstations, sensors, laboratory instruments, and related consumables; integrated systems for sample analyses; and detection technologies, including electrochemical and charged-aerosol detectors for the quantitative and qualitative analysis of biomolecules, microplate readers, and washers for microplate-based biomolecular immunoassays and liquid chromatography products. The company also offers laboratory-scale automation and software solutions, as well as blood culture, identification, and susceptibility technologies. It serves clinical-diagnostics and biomedical-research markets, as well as researchers in academic, government, pharmaceutical, biotech, and industrial laboratories. The company was founded in 2004 and is headquartered in Chelmsford, Massachusetts.